{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:55:18Z","timestamp":1761562518680,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.carrev.2019.01.027","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T04:47:24Z","timestamp":1548564444000},"page":"1053-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of Coronary Artery Revascularization Procedures in Patients with Antiphospholipid Syndrome"],"prefix":"10.1016","volume":"20","author":[{"given":"Navid","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himali","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliany Mejia","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraja","family":"Yedlapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Spevack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.carrev.2019.01.027_bb0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.autrev.2014.11.003","article-title":"Antiphospholipid syndrome and the heart: a case series and literature review","volume":"14","author":"Denas","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.carrev.2019.01.027_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0000000000000651","article-title":"The impact of primary antiphospholipid syndrome on long-term cardiovascular outcomes after percutaneous coronary intervention and stenting in patients with myocardial infarction","volume":"24","author":"Mora-Ramirez","year":"2018","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.carrev.2019.01.027_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MCA.0000000000000476","article-title":"Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review","volume":"28","author":"Nazir","year":"2017","journal-title":"Coron Artery Dis"},{"issue":"6","key":"10.1016\/j.carrev.2019.01.027_bb0020","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.17219\/acem\/63753","article-title":"Myocardial ischaemia, coronary atherosclerosis and pulmonary pressure elevation in antiphospholipid syndrome patients","volume":"25","author":"Padjas","year":"2016","journal-title":"Adv Clin Exp Med"},{"issue":"17","key":"10.1016\/j.carrev.2019.01.027_bb0025","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.carrev.2019.01.027_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13317-011-0017-9","article-title":"Pathophysiology of the antiphospholipid antibody syndrome","volume":"2","author":"Willis","year":"2011","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.carrev.2019.01.027_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/asheducation-2015.1.53","article-title":"The antiphospholipid syndrome: still an enigma","volume":"2015","author":"Chaturvedi","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.carrev.2019.01.027_bb0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1536\/ihj.46.631","article-title":"Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome","volume":"46","author":"G\u00fcrlek","year":"2005","journal-title":"Int Heart J"},{"issue":"12","key":"10.1016\/j.carrev.2019.01.027_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003200","article-title":"Impact of antiphospholipid syndrome and\/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"95","author":"Bundhun","year":"2016","journal-title":"Medicine"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919300995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919300995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:15:38Z","timestamp":1761560138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919300995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1553838919300995"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.01.027","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Coronary Artery Revascularization Procedures in Patients with Antiphospholipid Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}